Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of tolvaptan orally disintegrating vs conventional tablets in healthy males
jRCT1080223416Phase 1Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tolvaptan (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Bioequivalence between tolvaptan OD and conventional tablets. Started Dec 2016; status: completed.
02
Drugs
tolvaptan
Beyond the preview
Go deeper on jRCT1080223416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223416.